NCT02459652 Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT02459041 Clinical Impact of EUS Elastography Mean Strain Histograms (SH) and Contrast Peak-enhancement in Focal Pancreatic Masses and Lymph Nodes Status COMPLETED Phase N/A
NCT02457156 Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomy Status COMPLETED Phase PHASE3
NCT02454140 Stereotactic Body Radiotherapy Dose Escalation in Pancreatic Cancer Status COMPLETED Phase NA
NCT02451982 Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02449967 HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Pancreatic Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT02449135 Nano Drug Interventional Therapy Using Digital Subtraction Angiography(DSA) for Pancreatic Carcinoma Status NO_LONGER_AVAILABLE Phase N/A
NCT02446379 Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery Status WITHDRAWN Phase N/A
NCT02442739 Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers Status WITHDRAWN Phase EARLY_PHASE1
NCT02433626 Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies Status UNKNOWN Phase PHASE1
NCT02428270 A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT02424279 Invasive Treatment of Pain Associated With Pancreatic Cancer on Different Levels of WHO Analgesic Ladder Status UNKNOWN Phase NA
NCT02423954 Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) Status TERMINATED Phase PHASE1/PHASE2
NCT02423239 A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours Status UNKNOWN Phase PHASE1
NCT02416609 Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic Cancer Status UNKNOWN Phase NA
NCT02405585 Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT02403271 A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02400398 Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients Status COMPLETED Phase N/A
NCT02399137 A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2